DCP - Overview: Des-Gamma-Carboxy Prothrombin, Serum

Risk assessment of patients with chronic liver disease for development of hepatocellular carcinoma (HCC) Aiding in the monitoring of HCC patients post therapy if the des-gamma-carboxy prothrombin level was elevated prior to therapy